Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis
<a href="https://pixabay.com/users/fernandozhiminaicela/">fernandozhiminaicela</a> / Pixabay

Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis

According to a story from finanzen.at, the biotechnology company Orbsen Therapeutics recently announced that its immunotherapy product ORBCEL-C is to be tested in a multi-site clinical trial called MERLIN that…

Continue Reading
Close Menu